International Clinical Trial: Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure

Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779642) titled 'Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure' on Aug. 18.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Colorado, Denver

Condition: ARDS (Acute Respiratory Distress Syndrome) Acute Hypoxic Respiratory Failure

Intervention: Drug: Simvastatin

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: September 2026

Target Sample Size: 300

To know more, visit https://clinicaltrials.gov/study/NCT07779...